Skip to main content
letter
. 2021 Jun 11;154:4–6. doi: 10.1016/j.ejca.2021.05.036

Fig. 1.

Fig. 1

Quantitative SARS-CoV-2 spike IgG antibody levels in patients with (CoV-positive; N = 81) and without (CoV-negative; N = 94) prior SARS-CoV-2 infection after one dose of BNT162b2 (Pfizer/BioNtech) mRNA vaccine. Median titres (horizontal lines) of anti-S IgG were compared between CoV-positive and CoV-negative patients using a Mann-Whitney-U test.